AUS
NZ
UK
CA
USA
IND
_06_27_2025_01_29_51_988272.jpg)
Highlights
Aurora Cannabis urges shareholders to submit votes ahead of virtual meeting
Proxy deadline set shortly before annual general and special meeting
Expanded medical cannabis program and new strain offerings announced
Aurora Cannabis Inc. (TSE:ACB), a Canada-based cannabis company operating in both medical and adult-use markets, has issued a notice to its shareholders to participate in the upcoming annual general and special meeting. As a member of the broader cannabis industry listed on the s&p tsx venture composite index, the company continues to build its presence across several international markets.
Annual Meeting and Proxy Voting Details
The company will host its virtual shareholder meeting on a Friday afternoon in early August. To ensure participation, shareholders are encouraged to vote prior to the scheduled proxy deadline. The board of directors recommends supporting all listed director nominees and resolutions. The company emphasized that shareholder participation is important regardless of the number of shares held.
Shareholders seeking help with the voting process can reach out to the designated proxy advisory group via phone or email.
Corporate Portfolio and Global Presence
Aurora Cannabis markets a range of consumer and medical cannabis products. Its adult-use segment includes brands such as Drift, Daily Special, and San Rafael ’71. In the medical cannabis space, the company maintains several brands including Aurora, CanniMed, and MedReleaf. These brands support its operations across Canada and internationally in regions such as Europe, Australia, and New Zealand.
The company also maintains a controlling interest in Bevo Farms Ltd., which it describes as a major provider of propagated plants for agricultural use in North America.
Program Enhancements and Market Developments
Aurora has introduced updates to its medical cannabis pricing program in Canada. The threshold for compassionate pricing eligibility has been increased, aiming to improve access for a broader base of patients.
In Australia, the company has expanded its portfolio under the IndiMed label. Two new high-strength strains have been made available via MedReleaf Australia. These strains are designed to offer further therapeutic options to healthcare providers and patients.
The company has filed its latest regulatory report with the U.S. Securities and Exchange Commission, covering activities through the end of June. In response to recent media speculation, Aurora also issued a public statement denying any acquisition discussions involving MedLeaf Therapeutics.
Meeting Materials and Access
Shareholders can access official meeting documents via the Aurora Cannabis website or through the company's profile on SEDAR+. The virtual format of the meeting allows participation from various locations without requiring in-person attendance.
FAQs
- When is the deadline to vote on shareholder resolutions?
The deadline falls two days prior to the meeting, and votes must be submitted by the early afternoon. - Is the shareholder meeting in person or virtual?
The meeting will be conducted virtually, allowing shareholders to attend online. - Where can meeting documents be found?
Materials are available on the company’s official website and on its SEDAR+ profile.
